There has been an increase in the medical industry due to the rise in the human population. Also, the new generation has better spending power to buy better medicines due to which the medical sector has seen a boom. Due to the increased expenditures, there also have been more innovations that have necessitated technical pharma e-learning. Innovation is a great requirement of this industry because new diseases have been discovered.
What is the need for technical pharma e-learning?
Elearning is proving to be of considerable use in every industry, especially in those where updates happen frequently. It’s true that in the medical industry changes are happening every year. Many new drugs are approved and new devices also get launched.
Hence the technical pharma elearning is used to make sure that medical employees are informed of such changes.
When new drugs are introduced medical employees have to be taught about their administration. Classroom training proves to be inefficient in this regard because medical employees all over the US have to be updated which is a huge number.
In 2020 alone, 53 new drugs got into the market after approval from the CDER(Center for Drug Evaluation and Research) and hence the medical staff had to be taught about the right dosage.
The term “medical employees” is an umbrella term that encompasses physicians, specialists, drug distributors, etc who need to know the right use of the newly launched drug. Therefore, to train on such a massive scale is implausible, and hence technical pharma elearning is the best possible solution.
The paucity of good trainers: The benefit of training is that once it’s developed, it can be reused for new staff. Apart from that, the eLearning vendors have the time, to develop such courses because they can hire medical trainers. The medical staff does not have the time on their hands to develop such courses. Apart from, medical practitioners, the need for providing e-learning to medical students has also emerged. The medical schools want to remove lectures or lessen their number and even provide lab-based training through e-learning since the advent of virtual reality.
Impact of Covid-19
Medical employees have been trained so much ever since the Covid19 pandemic happened. For example, the compliance laws changed during the pandemic. The FDA issued new guidelines like the EUA which stands for Emergency Use Authorization. This implies that there has been an agreed use of unapproved medical drugs to treat this disease. It’s because the EUA authorizes the use of such drugs to diagnose and cure life-taking diseases when specific conditions are true such as no availability of approved alternatives.
FDA introduced EUA to make sure that the impact of Covid-19 was lessened and causalities could be prevented. There has been the issuance of EUA for using tests, and drugs for diagnosing and treating Covid-19.
Although a manufacturer can provide a EUA request for approval to the FDA, there have to be at least 3 clinical trials conducted for the drug. The drug should not have shown any negative impact in all three trials and exhibited positive results.
Technical pharma e-learning also became important for doctors who had to treat the Covid-19 patients. The patients who don’t have symptoms like fever may not be required to be admitted to a hospital, but this decision lies with the doctor whether the concerned person should be treated at home, which depends on factors like whether the patient can develop the disease severely or he can’t quarantine himself at home.
Also, doctors have to be made aware through technical pharma e-learning that in some patients, the pulse oximeter may not be the best way to measure oxygenation levels.
However, patients who are already showing severe symptoms of this disease have to be hospitalized. They have to be monitored for conditions such as pneumonia, respiratory failure, etc.
Technical pharma e-learning has proved to be useful for doctors in reporting patients who showed the Covid-19 symptoms. They first had to inform the infection control employees in their hospitals so that such patients could be tested for the disease. And once he/she tested positive, the test results had to be provided to the local health department.
This is how doctors got the required information from technical pharma e-learning during the pandemic.